Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 May-Jun;45(3):186-92.
doi: 10.1016/j.hrtlng.2016.01.005. Epub 2016 Mar 2.

A randomized controlled pilot trial to improve advance care planning for LVAD patients and their surrogates

Maureen Metzger  1 , Mi-Kyung Song  2 , Sandra Ward  3 , Patricia Pat-Yue Chang  4 , Laura C Hanson  4 , Feng-Chang Lin  5
Affiliations
Randomized Controlled Trial

A randomized controlled pilot trial to improve advance care planning for LVAD patients and their surrogates

Maureen Metzger et al. Heart Lung. 2016 May-Jun.

Abstract

Objectives: To examine feasibility, acceptability and preliminary effects of an advance care planning (ACP) intervention, SPIRIT-HF, in LVAD patients and their surrogates.

Background: LVADs may improve HF symptoms but they are not curative. Thus, ACP is needed to prepare patients and surrogates for end-of-life (EOL) decision-making.

Methods: Bridge to transplant and destination therapy LVAD patient-surrogate dyads were randomized to either SPIRIT-HF or usual care. Percentages of eligible dyads who were enrolled and completed the study determined feasibility. Analysis of interviews with SPIRIT dyads determined acceptability. Group comparisons of dyad congruence, patient's decisional conflict, and surrogate's decision-making confidence determined preliminary effects.

Results: Of 38 eligible dyads, 29 (76%) were enrolled, randomized, and completed the study. The 14 intervention dyads characterized SPIRIT-HF as beneficial. All dyads demonstrated improvement in outcomes. However, SPIRIT-HF dyads tended toward greater congruence on patient EOL treatment goals.

Conclusions: SPIRIT-HF is feasible and acceptable. Results will inform future trials.

Keywords: Advance care planning intervention; End-of-life care; Family members; LVADs; Surrogates.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Participants Progress in the Study
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke Statistics—2013 update: A report from the American Heart Association. Circulation. 2013;127(1):e6–e245. doi: 10.1161/CIR.0b013e31828124ad. - DOI - PMC - PubMed
    1. Byram EK. Upstream palliative care for the patient with a left ventricular assist device as destination therapy. Dimensions of Crit Care Nurs: DCCN. 2012;31(1):18–24. doi: 10.1097/DCC.0b013e31823a537c. - DOI - PubMed
    1. Lietz K. Destination therapy: Patient selection and current outcomes. J Card Surg. 2010;25(4):462–471. - PubMed
    1. Slaughter MS, Meyer AL, Birks EJ. Destination therapy with left ventricular assist devices: Patient selection and outcomes. Current Opinion in Cardiology. 2011;26(3):232–236. doi: 10.1097/HCO.0b013e328345aff4. - DOI - PubMed
    1. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant. 2014;33(6):555–564. doi: 10.1016/j.healun.2014.04.010. - DOI - PubMed

Publication types